Tourniquet test: Difference between revisions
No edit summary |
(→Method) |
||
| Line 8: | Line 8: | ||
A '''tourniquet test''' (also known as a Rumpel-Leede Capillary-Fragility Test or simply a capillary fragility test) determines [[capillary]] fragility. It is a clinical [[diagnostic]] method to determine a patient's [[bleeding|haemorrhagic]] tendency. It assesses fragility of capillary walls and is used to identify [[thrombocytopenia]] (a reduced [[platelet]] count). The test is defined by the [[World Health Organisation|WHO]] as one of the necessary requisites for diagnosis of [[Dengue fever]]. | A '''tourniquet test''' (also known as a Rumpel-Leede Capillary-Fragility Test or simply a capillary fragility test) determines [[capillary]] fragility. It is a clinical [[diagnostic]] method to determine a patient's [[bleeding|haemorrhagic]] tendency. It assesses fragility of capillary walls and is used to identify [[thrombocytopenia]] (a reduced [[platelet]] count). The test is defined by the [[World Health Organisation|WHO]] as one of the necessary requisites for diagnosis of [[Dengue fever]]. | ||
== | ==Methodology== | ||
A blood pressure cuff is applied and inflated to a point between the [[systolic]] and [[diastolic]] [[blood pressure]]s for five minutes. The test is positive if there are more than 20 [[petechiae]] per square inch (a petechia is a small red or purple spot on the body, caused by a minor hemorrhage). If the test is positive, a patient with sufficient pre-test probability may have [[dengue haemorrhagic fever]]. | |||
===Reliability=== | ===Reliability=== | ||
Latest revision as of 15:49, 14 June 2014
|
WikiDoc Resources for Tourniquet test |
|
Articles |
|---|
|
Most recent articles on Tourniquet test Most cited articles on Tourniquet test |
|
Media |
|
Powerpoint slides on Tourniquet test |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tourniquet test at Clinical Trials.gov Trial results on Tourniquet test Clinical Trials on Tourniquet test at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tourniquet test NICE Guidance on Tourniquet test
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tourniquet test Discussion groups on Tourniquet test Patient Handouts on Tourniquet test Directions to Hospitals Treating Tourniquet test Risk calculators and risk factors for Tourniquet test
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tourniquet test |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A tourniquet test (also known as a Rumpel-Leede Capillary-Fragility Test or simply a capillary fragility test) determines capillary fragility. It is a clinical diagnostic method to determine a patient's haemorrhagic tendency. It assesses fragility of capillary walls and is used to identify thrombocytopenia (a reduced platelet count). The test is defined by the WHO as one of the necessary requisites for diagnosis of Dengue fever.
Methodology
A blood pressure cuff is applied and inflated to a point between the systolic and diastolic blood pressures for five minutes. The test is positive if there are more than 20 petechiae per square inch (a petechia is a small red or purple spot on the body, caused by a minor hemorrhage). If the test is positive, a patient with sufficient pre-test probability may have dengue haemorrhagic fever.
Reliability
This test does not have high specificity. Factors that interfere with this test are women who are premenstrual, postmenstrual and not taking hormones, or those with sun damaged skin, since all will have increased capillary fragility.(Pagana, & Pagana, 1998; Tsai, 2000). At least one insurance company, Aetna, has determined that the Rumpel-Leede test is obsolete or unreliable and has been replaced by more advanced procedures. [2]